Billy Dunn, M.D.

Senior Advisor, Enigma Biomedical Group. Most recently, he spent 23 years as Head of the Neuroscience Office at the FDA, where he had a major impact on how drugs were developed for a range of neurological diseases.
meilleurtechnologies.com